本章信息参考了以下文献：
Abi-Dargham, A., D. R. Hwang, Y. Huang, Y. Zea-Ponce, D. Martinez, I. Lombardo, A. Broft, T. Hashimoto, M. Slifstein, O. Mawlawi, R. VanHeertum, and M. Laruelle. “Quantitative analysis of striatal and extrastriatal D2 receptors in humans with [18F]fallypride: Validation and reproducibility.” In preparation.
Ansorge, M. S., M. Zhou, A. Lira, R. Hen, and J. A. Gingrich. “Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice.” Science306 (2004): 879–81.
Baddeley, A. D. Working Memory. Oxford: Clarendon Press, 1986.
Carlsson, M. L., A. Carlsson, and M. Nilsson. “Schizophrenia: From dopamine to glutamate and back.” Curr. Med. Chem. 11, no. 3 (2004): 267–77.
Fuster, J. M. “The prefrontal cortex—an update: Time is of the essence.” Neuron30, no. 2 (2001): 319–33.
Goldman-Rakic, P. “The ‘psychic’ neuron of the cerebral cortex.” Ann. N. Y. Acad. Sci. 868 (1999): 13–26.
Huang, Y.-Y., E. Simpson, C. Kellendonk, and E. R. Kandel. “Genetic evidence for the bi-directional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors.” Proc. Natl. Acad. Sci. USA101 (2004): 3236–41.
Jacobsen, C. F. Studies of Cerebral Function in Primates. Baltimore: Johns Hopkins University Press, 1936.
Kandel, E. R. “Disorders of thought: Schizophrenia.” In Principles of Neural Science, 3rd ed., edited by E. R. Kandel, J. H. Schwartz, and T. M. Jessell, 853–68. New York: Elsevier, 1991.
Lawford, B. R., R. M. Young, E. P. Noble, B. Kann, L. Arnold, J. Rowell, and T. L. Ritchie. “D2 dopamine receptor gene polymorphism: Paroxetine and social functioning in posttraumatic stress disorder.” Euro. Neuropsychopharm. 13, no. 5 (2003): 313–20.
Santarelli, L., M. Saxe, C. Gross, A. Surget, F. Battaglia, S. Dulawa, N. Weisstaub, J. Lee, R. Duman, O. Arancio, C. Belzung, and R. Hen. “Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants.” Science301 (2003): 805–9.
Seeman, P., T. Lee, M. Chau-Wong, and K. Wong. “Antipsychotic drug doses and neuroleptic/dopamine receptors.” Nature261 (1976): 717–19.
Snyder, S. H. Drugs and the Brain. New York: Scientific American Books, 1986.
Schwartz, J. M., P. W. Stoessel, L. R. Baxter, K. M. Martin, and M. E. Phelps. “Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorders.” Arch. Gen. Psychiatry53 (1996): 109–13.
